Opinion: Bulls may be losing enthusiasm for stocks, but these 3 potential takeover plays could land in the money
The U.S. stock market, as measured by the S&P 500 Index SPX, -0.56%, had finally broken out over triple resistance ...
Read moreDetailsThe U.S. stock market, as measured by the S&P 500 Index SPX, -0.56%, had finally broken out over triple resistance ...
Read moreDetailsIf you are investing in dividend stocks, the last thing you want to see is a company cutting its payout. ...
Read moreDetailsBusinessAsiaA brief seller’s allegations of fraud by Gautam Adani’s conglomerate centre on whether or not his family wielded influence in ...
Read moreDetailsIn the biggest week of the holiday-earnings season, Big Tech results will receive the spotlight amid thousands of layoffs that ...
Read moreDetailsPfizer’s PFE, -.92% early-stage pipeline, even though promising, is continue to also premature to make up for the looming loss ...
Read moreDetailsText dimensions Stock and bond markets will be shut on Monday for Martin Luther King Jr. Day. It will be ...
Read moreDetailsText dimension Stock and bond markets will be closed on Monday for Martin Luther King Jr. Day. It will be ...
Read moreDetailsRoundtableMarketplacesBullish or bearish, our 10 panelists assist make perception of progressively sophisticated industry dynamics. Moreover: 9 inventory picks.Current Jan. 15, ...
Read moreDetailsVirtually two years following biotechnology shares began to tumble, executives at modest and midsize corporations in the room are lastly ...
Read moreDetailsAstraZeneca agreed to acquire U.S. biotech firm CinCor Pharma in a deal perhaps valued at $1.8 billion, the British pharmaceutical ...
Read moreDetailsEmail Contact: souhaib@trendswide.com